about
Quantifying the roles of host movement and vector dispersal in the transmission of vector-borne diseases of livestock.Impact and cost-effectiveness of new tuberculosis vaccines in low- and middle-income countriesTuberculosis control in South African gold mines: mathematical modeling of a trial of community-wide isoniazid preventive therapy.Systematic review of mathematical models exploring the epidemiological impact of future TB vaccines.Is IPT more effective in high-burden settings? Modelling the effect of tuberculosis incidence on IPT impact.Ability of preventive therapy to cure latent Mycobacterium tuberculosis infection in HIV-infected individuals in high-burden settings.An evaluation of tuberculosis contact investigations against national standards.Feasibility of achieving the 2025 WHO global tuberculosis targets in South Africa, China, and India: a combined analysis of 11 mathematical models.A Comparison of Dynamics in Two Models for the Spread of a Vector-Borne Disease.Cost-effectiveness and resource implications of aggressive action on tuberculosis in China, India, and South Africa: a combined analysis of nine models.Post-treatment effect of isoniazid preventive therapy on tuberculosis incidence in HIV-infected individuals on antiretroviral therapy.A composite computational model of liver glucose homeostasis. I. Building the composite model.A composite computational model of liver glucose homeostasis. II. Exploring system behaviour.A methodology for global-sensitivity analysis of time-dependent outputs in systems biology modelling.Catastrophic costs potentially averted by tuberculosis control in India and South Africa: a modelling study.TIME Impact - a new user-friendly tuberculosis (TB) model to inform TB policy decisions.Scaling from challenge experiments to the field: Quantifying the impact of vaccination on the transmission of bluetongue virus serotype 8.Comparison of pre-emptive and reactive strategies to control an incursion of bluetongue virus serotype 1 to Great Britain by vaccination.A novel blood test for tuberculosis prevention and treatment.Evidence-informed policy making at country level: lessons learned from the South African Tuberculosis Think Tank.Transmission events revealed in tuberculosis contact investigations in London.Global tuberculosis targets and milestones set for 2016-2035: definition and rationale.Empirical estimation of resource constraints for use in model-based economic evaluation: an example of TB services in South AfricaShould NICE reconsider the 2016 UK guidelines on TB contact tracing? A cost-effectiveness analysis of contact investigations in LondonA Bayesian Approach to Understanding Sex Differences in Tuberculosis Disease BurdenApplication of provincial data in mathematical modelling to inform sub-national tuberculosis program decision-making in South AfricaEstimating the Impact of Tuberculosis Case Detection in Constrained Health Systems: An Example of Case-Finding in South Africa.Age-targeted tuberculosis vaccination in China and implications for vaccine development: a modelling studyPotential population level impact on tuberculosis incidence of using an mRNA expression signature correlate-of-risk test to target tuberculosis preventive therapy
P50
Q33570965-6060D2D3-F0A6-40D8-9F5B-B5DFAEC66507Q34441930-7EE4947E-CBB3-4A87-8EA8-CEB9F90EF1CAQ35297467-C33F88D2-2024-4714-81C7-40854FE26D19Q37473293-B5FD79C1-FAA8-4E16-9949-F1DF5F1DAAEEQ37514147-5CD43F39-E898-477C-9665-EF517641C314Q37702101-90C4B349-69A6-4CB8-9E79-4939B5F9088EQ38847143-A2FEE331-D010-4565-BD85-4B65430E409AQ39079068-5278BFBE-C099-4E0C-AA8C-2392A2CBA286Q39154886-48A1F253-A984-4CA1-8EBF-9E5AF5B60D99Q39245552-2A4F87A7-9B22-4511-A806-1CF809D359BEQ39497926-4CB64725-EC60-4741-B982-5A03FBB0F90BQ41421278-8340DEB9-3EE3-4BD0-813B-D3BECA4DC81DQ41423781-651DC7DA-DE9C-44BB-AD3E-3A1CF3648154Q42041010-49C3800E-E25C-4EAA-845C-06C122AD620CQ42377337-F8F9C541-6F1D-4BB2-AEDB-03B868B1C54BQ42936293-20EBAEC7-E1FF-4F82-AB3D-08B5C45E14FCQ44405640-F2FCC99F-01AB-47E9-B2DA-C5DFF55F622BQ45358567-D4F5BC32-135F-4A9C-BBA6-5F1633174528Q53740357-A05C485A-B894-46F4-AFCD-9BDC551B214EQ54940389-62D0FC5A-1466-4F17-B875-ECCBA704EFAAQ55396455-CEDB28FC-EA35-4FF1-8CC0-28117EBB7530Q55417764-FEA98B18-3F5A-415C-9C47-2D09A753EEC3Q57174113-1CBD0E15-1D09-422A-85C3-75F1800A22A6Q59181262-4484726C-939C-41FC-A267-6DEC3A63CD69Q59181267-0D33514E-6D8B-4654-AD98-56BA1F4DEF57Q61809898-06D8F838-1D77-403E-9F86-0569F215110CQ64913555-C53694E1-34AB-4CEE-A892-4FD85A844609Q90988221-13CE8643-B845-4F75-B8B3-216968955E2AQ92322126-38B706E8-4955-4F1E-B056-7A2EED6C0BA3
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
T Sumner
@ast
T Sumner
@en
T Sumner
@es
T Sumner
@nl
type
label
T Sumner
@ast
T Sumner
@en
T Sumner
@es
T Sumner
@nl
prefLabel
T Sumner
@ast
T Sumner
@en
T Sumner
@es
T Sumner
@nl
P106
P31
P496
0000-0001-9305-534X